Bresson-Dumont H, Aptel F
Clinique Sourdille Nantes, 3, place Anatole-France, 44046 Nantes, France.
J Fr Ophtalmol. 2011 Jun;34(6):413-5. doi: 10.1016/j.jfo.2011.03.008. Epub 2011 May 12.
In clinical practice, the vascular factor seems to be essential in glaucoma. Nevertheless, the various studies investigating the relations between the changes in ocular blood flow and risk of glaucoma often have diverse and contradictory conclusions. The variety of the methods in studies on ocular blood flow, the absence of a reference examination, and the absence of large clinical studies probably explain the problems bringing to light an indisputable relation. However, it remains essential, in any glaucoma, to look for and treat the vascular risk factor and most particularly to decrease intraocular pressure, the treatment that currently remains the most reliable to improve ocular blood flow.
在临床实践中，血管因素在青光眼发病过程中似乎至关重要。然而，各项关于眼血流变化与青光眼风险之间关系的研究，其结论往往多种多样且相互矛盾。眼血流研究方法的多样性、缺乏对照检查以及缺乏大型临床研究，可能是导致难以揭示明确关系的原因。然而，在任何青光眼病例中，寻找并治疗血管危险因素仍然至关重要，尤其是降低眼压，目前这仍是改善眼血流最可靠的治疗方法。
